MedTrace Logo

Angelman Syndrome Natural History Study-FAST UK

NCT05100810 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-02-28

No results posted yet for this study

Summary

The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of Angelman syndrome (AS) in children and adults. This will be performed by acquiring baseline measurements, and developing effective outcome measures and diagnostic tools for the syndrome, to prepare the healthcare system for forthcoming clinical trials.

Conditions

Interventions

OTHER

Natural History Study

Longitudinal assessment of disease progression of Angelman syndrome in patients

Sponsors & Collaborators

  • Foundation for Angelman Syndrome Therapeutics UK

    collaborator UNKNOWN

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • University of Oxford

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100810 on ClinicalTrials.gov